Catalyst Wire Dossier Catalyst Wire Dossier

VIGIV

Vaccinia immune globulin intravenous · Emergent BioSolutions
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VIGIV, covering 2022-10-26 to 2025-10-08. Get the full timeline:

Most recent: Clinical Trial Update: VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection

See pricing